Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type

Rapid inactivation of Ebola virus (EBOV) is crucial for high-throughput testing of clinical samples in low-resource, outbreak scenarios. The EBOV inactivation efficacy of Buffer AVL (Qiagen) was tested against marmoset serum (EBOV concentration of 1 × 10(8) 50% tissue culture infective dose per mill...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Microbiol
Main Authors: Smither, Sophie J., Weller, Simon A., Phelps, Amanda, Eastaugh, Lin, Ngugi, Sarah, O'Brien, Lyn M., Steward, Jackie, Lonsdale, Steve G., Lever, Mark S.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2015
Teme:
Virology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4572529/
https://ncbi.nlm.nih.gov/pubmed/26179307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01449-15
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki